Cargando…
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
Tumour budding predicts survival of stage II colorectal cancer (CRC) and has been suggested to be associated with epithelial‐to‐mesenchymal transition (EMT). However, the underlying molecular changes of tumour budding remain poorly understood. Here, we performed multiplex immunohistochemistry (mIHC)...
Autores principales: | Slik, Khadija, Blom, Sami, Turkki, Riku, Välimäki, Katja, Kurki, Samu, Mustonen, Harri, Haglund, Caj, Carpén, Olli, Kallioniemi, Olli, Korkeila, Eija, Sundström, Jari, Pellinen, Teijo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317060/ https://www.ncbi.nlm.nih.gov/pubmed/30358171 http://dx.doi.org/10.1002/cjp2.119 |
Ejemplares similares
-
Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2017) -
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
por: Blom, Sami, et al.
Publicado: (2017) -
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer
por: Pellinen, Teijo, et al.
Publicado: (2022) -
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
por: Hohtari, Helena, et al.
Publicado: (2019) -
Fibroblast as a critical stromal cell type determining prognosis in prostate cancer
por: Blom, Sami, et al.
Publicado: (2019)